Royal Bank of Canada
ZOM

Royal Bank of Canada’s Zomedica Corp. ZOM Stock Holding History

Royal Bank of Canada’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,225
Closed – – 7419
2024
Q4 		$0 Buy
3,225
+475
+17% +$60 ﹤0.01% 7447
2024
Q3 		$0 Sell
2,750
-1,341
-33% -$188 ﹤0.01% 7767
2024
Q2 		$0 Buy
4,091
+3,200
+359% +$479 ﹤0.01% 7810
2024
Q1 		$0 Sell
891
-2,385
-73% -$334 ﹤0.01% 7893
2023
Q4 		$0 Buy
3,276
+66
+2% +$12 ﹤0.01% 7920
2023
Q3 		$0 Sell
3,210
-154,601
-98% -$30K ﹤0.01% 7985
2023
Q2 		$31K Sell
157,811
-213
-0.1% -$43 ﹤0.01% 6002
2023
Q1 		$34K Buy
158,024
+93,804
+146% +$23K ﹤0.01% 5822
2022
Q4 		$10K Sell
64,220
-713
-1% -$146 ﹤0.01% 6564
2022
Q3 		$14K Buy
64,933
+25,462
+65% +$6.74K ﹤0.01% 6291
2022
Q2 		$9K Buy
39,471
+36,726
+1,338% +$9.35K ﹤0.01% 6442
2022
Q1 		$1K Sell
2,745
-2,684
-49% -$878 ﹤0.01% 7680
2021
Q4 		$2K Sell
5,429
-3,571
-40% -$1.61K ﹤0.01% 7463
2021
Q3 		$5K Sell
9,000
-1,297
-13% -$765 ﹤0.01% 7176
2021
Q2 		$9K Sell
10,297
-16,280
-61% -$15.2K ﹤0.01% 6930
2021
Q1 		$42K Buy
26,577
+23,918
+900% +$39.1K ﹤0.01% 6008
2020
Q4 		$0 Sell
2,659
-484
-15% -$62 ﹤0.01% 7529
2020
Q3 		$0 Hold
3,143
– – ﹤0.01% 7205
2020
Q2 		$1K Hold
3,143
– – ﹤0.01% 6560
2020
Q1 		$0 Sell
3,143
-1
-0% – ﹤0.01% 7234
2019
Q4 		$1K Buy
3,144
+393
+14% +$132 ﹤0.01% 6748
2019
Q3 		$1K Buy
2,751
+657
+31% +$204 ﹤0.01% 6606
2019
Q2 		$0 Buy
2,094
+2
+0.1% +$1 ﹤0.01% 7364
2019
Q1 		$1K Sell
2,092
-477
-19% -$421 ﹤0.01% 6720
2018
Q4 		$3K Sell
2,569
-1,755
-41% -$2.78K ﹤0.01% 6396
2018
Q3 		$9K Buy
4,324
+1,852
+75% +$3.96K ﹤0.01% 6057
2018
Q2 		$5K Buy
2,472
+164
+7% +$329 ﹤0.01% 6071
2018
Q1 		$5K Buy
2,308
+308
+15% +$632 ﹤0.01% 5957
2017
Q4 		$4K Buy
+2,000
New +$4.44K ﹤0.01% 6158

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

Royal Bank of Canada's ZOM Position: Q1 2025 in Review

Royal Bank of Canada sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 3,225 shares.

Royal Bank of Canada first reported a position in ZOM in Q4 2017 and held it in 29 quarters. The position peaked at $42K in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Royal Bank of Canada reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 3,225 Zomedica Corp. shares in Q1 2025.
  • Royal Bank of Canada first reported a position in Zomedica Corp. in Q4 2017 and held it in 29 quarters.
  • Royal Bank of Canada's Zomedica Corp. position peaked at $42K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.